Dr. Mark Juhl, MD

Dr. Juhl practices at Minden Dermatology in Minden, Nevada.

Dr. Juhl's NPI, 1912391897, was assigned on March 27, 2015. Dr. Juhl graduated from University of Illinois College of Medicine - Chicago in 2015. Dr. Juhl holds Nevada license 20876.

Dr. Juhl's primary practice is Minden Dermatology, at 1624 10th St, Minden, NV 89423 in Douglas County. The practice phone is (775) 782-0700.

Dr. Juhl's primary practice is Minden Dermatology in Minden, Nevada. Dr. Juhl is also affiliated with Carson Tahoe Regional Medical Center. The medical group on file is Minden Dermatology. Dmand AI also links Dr. Juhl to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Juhl practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Juhl's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Juhl is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Juhl's licenses on file in 3 states: Nevada, California and Illinois.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. Juhl treats.

CMS data shows 6,317 Medicare services from Dr. Juhl across 30 procedure codes in 2024, for 673 Medicare patients. Medicare paid $470,142 for them. Every service was in an office.

CMS counts 673 Medicare patients who saw Dr. Juhl in 2024. The largest group is 65 to 74, with 301 patients. 71% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Juhl's median patient age at 65, with 55% women.

In 2024, Dr. Juhl wrote 371 Medicare Part D claims for 169 patients. 99% of them were for generic drugs. CMS names the drug for 275 of them, across 7 drugs with 11 or more claims each, at $8,354 in total drug cost. In 2023, CMS named 291 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Juhl for performance year 2024, reported individually. Dr. Juhl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 758 procedures of skin biopsy by Dr. Juhl, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Juhl, published from 2014 to 2022. 2015 was the busiest year, with 3. The most frequent topics are Administration, Cutaneous. Dr. Juhl has published most often in Acta Derm Venereol. Dr. Juhl's most frequent co-authors are Sonoa Ho Yee Au, MD, Michelle Bene Bain, MD and Gaurav Agnihotri, MD.

CMS Open Payments shows 64 general payments to Dr. Juhl from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $787.

Dr. Juhl graduated from University of Illinois College of Medicine - Chicago in 2015.

Dr. Juhl is in network with 8 carriers, including United Healthcare, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.